Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Characterization and Treatment Pathways of Heavy Menstrual Bleeding (HMB)

NCT05176496 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT05176496
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05176496 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Characterization and Treatment Pathways of Heavy Menstrual Bleeding (HMB)
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
November 30, 2021
Completion date
July 15, 2023
Enrollment
99,999 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heavy menstrual bleeding